Safe lists for medications in pregnancy: Inadequate evidence base and inconsistent guidance from Web-based information, 2011

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 3, 2013, Pages 324-328

  Peters, Stacey L ^a,b   Lind, Jennifer N ^b,c   Humphrey, Jasmine R ^a,b   Friedman, Jan M ^d   Honein, Margaret A ^b   Tassinari, Melissa S ^e   Moore, Cynthia A ^b   Mathis, Lisa L ^e   Broussard, Cheryl S ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Drug safety; Internet; Medication; Pharmacoepidemiology; Pregnancy; TERIS; Women

Indexed keywords

BISACODYL; BISMUTH SALICYLATE; CETIRIZINE PLUS PSEUDOEPHEDRINE; CHLORPHENIRAMINE MALEATE; CLARITIN D; CODEINE; DIHYDROXYALUMINUM SODIUM CARBONATE; DIMETAPP; DIPHENHYDRAMINE; DOCUSATE CALCIUM; DOXYLAMINE; ERYTHROMYCIN; LORATADINE; METRONIDAZOLE; OXYMETAZOLINE; PARACETAMOL; PHENYLEPHRINE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; TERBINAFINE;

ARTICLE; BIRTH DEFECT; DRUG SAFETY; EVIDENCE BASED PRACTICE; FETUS RISK; HUMAN; INTERNET; MEDICAL INFORMATION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ABNORMALITIES, DRUG-INDUCED; ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG INFORMATION SERVICES; DRUG THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION SEEKING BEHAVIOR; INTERNET; PATIENT SAFETY; PHARMACOEPIDEMIOLOGY; PREGNANCY; RISK ASSESSMENT; RISK FACTORS;

EID: 84874521076     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3410     Document Type: Article

References (12)

1. Hesse BW, Nelson DE, Kreps GL, Croyle RT, Arora NK, Rimer BK, Viswanath K. Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med 2005; 165(22): 2618-2624. DOI: 10.1001/archinte.165.22.2618.
2. Petersen EE, Rasmussen SA, Daniel KL, Yazdy MM, Honein MA. Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) 2008; 17(7): 1073-1080. DOI: 10.1089/jwh.2007.0769.
3. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernandez-Diaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 2011; 205: 51.e1-51.e8. DOI: 10.1016/j.ajog.2011.02.029.
4. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet Part C Semin Med Genet 2011; 157: 175-182. DOI: 10.1002/ajmg.c.30313.
5. Friedman JM, Polifka JE. 2011. TERIS. Micromedex reproductive risk information system (REPRORISK). Englewood, Colorado: Thomson MICROMEDEX (accessed 2 November 2011).
6. U.S. Food and Drug Administration. Summary of Proposed Rule on Pregnancy and Lactation Labeling. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093310.htm (accessed 15 December 2011).
7. National Center for Health Statistics. National Vital Statistics Report. Births: Preliminary data for 2008. Hyattsville, MD: 2009.
8. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011; 84(5): 478-485. DOI: 10.1016/j.contraception.2011.07.013.
9. Broussard CS, Louik C, Honein MA, Mitchell AA. Herbal use before and during pregnancy. Am J Obstet Gynecol 2010; 202(5): e441-e446. DOI: 10.1016/j.ajog.2009.10.865.
10. Friedman JM. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 2000; 62(2): 134-137. DOI: 10.1002/1096-9926(200008)62:2<134::aid-tera10>3.0.co;2-d.
11. U.S. Food and Drug Administration. Dietary Supplement Labeling Guide. Updated April 2005. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/DietarySupplements/DietarySupplementlabelingguide/default.htm (accessed 6 March, 2012).
12. Obican S, Scialli AR. Teratogenic exposures. Am J Med Genet C Semin Med Genet 2011; 157(3): 150-169. DOI: 10.1002/ajmg.c.30310.